Pediatricians need to ask about nonprescription substance use during pregnancy when taking histories from mothers with opioid dependence to better care for their newborns.
Recommendations from the American Gastroenterological Association (AGA) for the medical management of opioid-induced constipation (OIC).
Chronic opioid use during pregnancy that causes neonatal abstinence syndrome is associated with smaller neonatal head circumference.
An ultrarestrictive opioid prescription protocol can reduce the number of opioids prescribed to patients after gynecologic and abdominal surgery without negative health consequences.
Military patients whose primary care clinicians participated in a telementoring program have larger declines in opioid-related prescriptions than patients whose clinicians did not participate.
The quantity of opioids prescribed after surgery is associated with patient-reported opioid consumption.
The number of opioid overdose deaths in the United States reached a new record last year with 72,000 deaths, which works out to about 200 a day.
Ruling against the recommendation of one of its chief experts, the US FDA approved an extremely potent new opioid painkiller, Dsuvia.
Many patients in a workers' compensation cohort have persistent opioid use.
A bipartisan bill meant to combat the United States' opioid abuse epidemic was signed into law October 24 by President Donald Trump.
Receiving prescriptions from both the US Department of Veterans Affairs and Medicare Part D is associated with increased risk for overlapping of opioid and benzodiazepine prescriptions.
A bipartisan bill to fight the opioid addiction crisis in the United States has been passed by Congress.
An "enhanced recovery after surgery" program is associated with a significant reduction in opioid consumption after gynecologic surgery with no increase in pain scores.
In a rare bipartisan move, both the House and Senate have reached a compromise on legislation to address the opioid epidemic.
Potentially inappropriate prescribing (PIP) of opioids is associated with increased risk of all-cause mortality and fatal and nonfatal overdose.
As part of the REMS program, drug companies with approved opioid analgesics must make training available to prescribers and provide unrestricted grants to accredited continuing education providers for the development of education courses.
Many outpatient opioid prescriptions have no documented medical indication.
Purdue Pharma, the maker of Oxycontin who some have blamed for the epidemic of opioid painkiller addictions, has patented a medicine aimed at curbing those disorders.
Among surgical patients who develop new persistent opioid use, surgeons provide the majority of opioid prescriptions in the first few months after surgery.
A $3.4 million grant to help a non-profit company develop a less expensive opioid overdose antidote was announced by Purdue Pharma, which makes the opioid painkiller OxyContin.
The new plan will break out the current guidance into 4 separate guidances.
Rates of opioid use in the United States do not appear to be declining.
Four more online networks that operate 21 websites illegally selling potentially dangerous, unapproved, and misbranded versions of opioid pain medications have been told to immediately stop their sales.
Concomitant exposure to pregabalin and opioids is associated with increased odds of opioid-related death.
Last year, the DEA proposed a 20% reduction in the manufacturing of controlled substances for 2018 compared to 2017.
Children often fill outpatient opioid prescriptions, with the most common indication for dental procedures.
A novel, innovative initiative is being developed to help end addiction over the long term.
Use of medications for opioid use disorder is associated with a reduction in all-cause and opioid-related mortality after opioid overdose.
The US Drug Enforcement Administration's 2014 ruling to reschedule hydrocodone combination products coincided with an increase in illicit trading of opioids through online illicit markets.
Nine online networks have been warned that they must stop illegally marketing potentially dangerous, and misbranded versions of opioid medications.
Neurology Advisor Articles
- Ocrelizumab Reduces Upper Extremity Disability Progression Risk in PPMS
- Cerebellar Stimulation May Help Improve Gait and Balance Recovery in Stroke
- Hydrocephalus May Be a Complication of Congenital Zika Syndrome
- Psychotherapy May Reduce Frequency of Nonepileptic Seizures
- Can Early Initiation of Direct Oral Anticoagulants Prevent Recurrent AFib-Related Stroke?
- Very Early Mobilization After Stroke Does Not Improve Survival Over Usual Care
- Alemtuzumab Linked to Clinical and MRI Disease Remission in Multiple Sclerosis
- Cognitive Decline Worsens With Memantine, ChEIs in Patients With Alzheimer's
- Cervical Dysfunction Needs Clarification to Identify Link With Headache
- Levodopa Inhalation Powder Approved for Parkinson Disease
- Repeated Botulinum Neurotoxin Type A Injections Increase Antibody Development
- Cortical Thinning in Specific Brain Regions May Be Associated With Migraine
- Daily Fruit/Vegetable Consumption May Prevent Poor Cognitive Function in Men
- Less Deep Sleep in Elderly Tied to Alzheimer Disease Markers
- Private Equity Acquisition of Physician Practices Discussed